Funding Opportunities

Synopsis of Current Program Announcements


FY13 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Therapeutic Development Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $1,500,000 in direct costs.
  • More cost-effective studies not requesting the full funding amount are encouraged.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application: June 5, 2013
Pre-application is required; Application submission is by invitation only
Application: September 18, 2013
Therapeutic Idea Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $400,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application: June 5, 2013
Pre-application is required; Application submission is by invitation only
Application: September 18, 2013

FY13 Bone Marrow Failure Research Program (BMFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions (external link)
April 26, 2013
  • Maximum funding of $360,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 3 years
Pre-Application: June 26 2013
Application: September 17, 2013

FY14 Defense Medical Research and Development Program (DMRDP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
FY14 Military Infectious Diseases Applied Research Award (MID-ARA) Program Announcement
Application Instructions (external link)
April 24, 2013
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $2,000,000 in total costs (direct + indirect)
  • A Partnering PI may be included in the application but the combined total funding for both PIs may not exceed $2,000,000
  • Subject to availability of funding, approximately 5 MID-ARA applications will be awarded
Pre-Application: June 10, 2013
Application: September 30, 2013

FY13 Multiple Sclerosis Research Program (MSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • Maximum funding of $400,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years
Pre-Application (Preproposal): June 18, 2013.
Preproposal is required; Application submission is by invitation only.
Application: September 17, 2013.

FY13 Neurofibromatosis Research Program (NFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $900,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013
Exploration - Hypothesis Development Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013
Investigator-Initiated Research Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $525,000 in direct costs ($575,000 in direct costs if requesting an Optional Qualified Collaborator or $675,000 in direct costs if requesting an Optional Nested Postdoctoral Fellow).
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013
New Investigator Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $400,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013

FY13 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Ovarian Cancer Academy Award Program Announcement
Application Instructions (external link)
April 28, 2013
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
  • Anticipate 2 awards.
Pre-Application: June 12, 2013
Application: August 28, 2013
Pilot Award Program Announcement
Application Instructions (external link)
April 27, 2013
  • Maximum funding of $225,000 for direct costs (plus indirect costs).
  • Maximum funding of $300,000 for direct costs with a qualified nested Teal Postdoctoral Scholar (plus indirect costs).
  • Period of performance not to exceed 2 years.
  • Anticipate 15 awards.
Pre-Application: June 12, 2013
Application: August 28, 2013
Teal Innovator Award Program Announcement
Application Instructions (external link)
April 27, 2013
  • Maximum funding of $2,500,000 for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
  • Anticipate 1 award.
Pre-Application: June 12, 2013
Application: August 28, 2013

FY13 Peer Reviewed Orthopaedic Research Program (PRORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount
Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions (external link)
February 21, 2013
  • Maximum funding of $2.5M for direct costs (plus indirect costs)
  • Period of performance up to 4 years
  • Nested Career Development: Additional direct costs of $225K for total combined direct costs of $2.725M
Pre-Application (Preproposal): April 4, 2013
Application: July 18, 2013
Clinical Trial Development Award Program Announcement
Application Instructions (external link)
February 21, 2013
  • Maximum funding of $200,000 for direct costs (plus indirect costs)
  • Period of performance up to 18 months.
Pre-Application (Preproposal): April 4, 2013
Application: July 18, 2013
Translational Research Award Program Announcement
Application Instructions (external link)
February 21, 2013
  • Maximum combined funding of $750K for direct costs (plus indirect costs)
  • Period of performance up to 3 years
  • Nested Career Development: Additional direct costs of $225K for total combined direct costs of $975K
Pre-Application (Preproposal): April 4, 2013
Application: July 18, 2013
Idea Development Award Program Announcement
Application Instructions (external link)
February 21, 2013
  • Maximum funding of $500K for direct costs (plus indirect costs)
  • Period of performance up to 3 years
  • Nested Career Development: Additional direct costs of $225K for total combined direct costs of $725K
Pre-Application (Preproposal): April 4, 2013
Application: July 18, 2013

FY13 Psychological Health/Traumatic Brain Injury (PH/TBI)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Traumatic Brain Injury Research Award Program Announcement
Application Instructions
January 23, 2012
  • The maximum period of performance is 3 years.
  • The maximum allowable total costs for the entire period of performance are $3,000,000 inclusive of indirect costs for clinical studies including clinical trials and $1,000,000 inclusive of indirect costs for applied and or mechanistic studies.
Pre-Application: February 27, 2013
Application: May 30, 2013
Basic/Applied Psychological Health Award Program Announcement
Application Instructions (external link)
March 5, 2013
  • The maximum period of performance is 4 years.
  • For basic research awards, the maximum allowable direct costs for the entire period of performance is $1,000,000 plus indirect costs.
  • For applied research and combined awards, the maximum allowable direct costs for the entire period of performance cannot exceed $4,000,000 plus indirect costs.
  • Subject to availability of funding, approximately 5-10 Basic/Applied Psychological Health Award applications will be awarded.
Pre-Application: April 16, 2013
Application: July 23, 2013

FY13 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013
Idea Development Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $425,000 in direct costs ($575,000 in direct costs if requesting an Optional Qualified Collaborator or Postdoctoral Fellow).
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013
Pilot Clinical Trial Award Program Announcement
Application Instructions (external link)
May 3, 2013
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $200,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 27, 2013
Application: July 11, 2013